A practical guide to merger control and regulatory clearances for an Asia deal

An Asian deal with a Hong Kong holding layer, a Mainland operating entity and an offshore acquirer does not produce a single clearance question. It produces several, running in parallel across jurisdictions that do not share a common clock. Miss one gate, and closing is delayed or unwound. Get the sequence right, and the deal moves on its own timetable.

Merger control and regulatory clearances for an Asia deal require a structured assessment of every jurisdiction in which thresholds are triggered, conducted before signing, so that the correct conditions precedent are built into the transaction documents and the closing timeline reflects the actual regulatory sequence. The governing instruments vary by jurisdiction – from the Anti-Monopoly Law administered by the State Administration for Market Regulation on the Mainland, to sector-specific regimes in Hong Kong, to foreign-investment review regimes in buyer and target home markets – and they do not pause for each other. The first task of cross-border counsel is to map that perimeter completely before any document is signed.

This guide sets out the practical sequence in the order it runs, flags the gate at each step, identifies the mistake that most commonly delays or derails the process, and closes with a decision checklist for in-house counsel managing an Asia-facing transaction.

Why does an Asia deal present a different clearance problem from a European or US transaction?

An Asia deal is structurally more complex from a regulatory standpoint because multiple review regimes operate simultaneously without any co-ordinating mechanism between them. A European transaction typically presents a clear allocation between the European Commission and national authorities. An Asia deal adds a Mainland merger-filing obligation, a potential Hong Kong sectoral consent, a foreign-investment review in the buyer's home jurisdiction, and possibly a further review in a Southeast Asian market – each with its own timeline, its own information standard and its own set of reviewers who do not speak to one another.

The second distinguishing feature is the structure of the deal itself. Most Asia transactions involve a holding entity in the BVI or the Cayman Islands sitting above a Hong Kong intermediate and a Mainland waiziqi (foreign-invested enterprise) operating company. That structure is commercially efficient, but it multiplies the number of competent authorities. Each layer of the structure potentially sits in a different regulatory perimeter.

The third feature is that Hong Kong does not operate a general pre-merger notification regime. There is no equivalent to the EU Merger Regulation or the Hart-Scott-Rodino process. Sector-specific rules apply in telecommunications, broadcasting and certain financial-services licences, but the default position is that a straightforward share acquisition in Hong Kong does not trigger a mandatory pre-deal filing with a competition authority. That absence is not an exemption. It means the analysis must look through the Hong Kong holding layer to the jurisdictions where the operating assets, the customers and the revenues sit.

In our cross-border M&A practice, that mapping exercise is the first task we undertake when a new mandate arrives. The holding structure may look clean on paper. The regulatory perimeter almost never is.

Step 1: Mapping the regulatory perimeter – where do the thresholds actually bite?

The first step is a systematic threshold analysis across every jurisdiction in which the target group, the acquirer group, or the combined group holds meaningful revenues, assets or market share. This is a desk exercise that must be completed before the signing timeline is fixed, because the output determines the critical path.

The analysis runs in four layers. First, identify which jurisdictions have mandatory pre-closing notification regimes. The Mainland's Anti-Monopoly Law is the most consequential for an Asia deal involving PRC-nexus assets or revenues: it operates a filing obligation keyed to combined global turnover thresholds and China-specific turnover thresholds, and closing before clearance is prohibited. The exact thresholds are set by regulation and are subject to revision; in-house counsel should verify the current figures with their advisers before signing a timeline.

Second, identify jurisdictions with voluntary but practically mandatory pre-closing reviews. Some markets impose no formal obligation but have a track record of using post-closing review powers aggressively. Building a voluntary notification into the timeline is often the lower-risk choice.

Third, identify sectoral consents that operate independently of the competition regime. A licence transfer in a regulated sector – banking, insurance, payments, telecommunications – may require regulatory approval from a sector-specific body whose timetable is entirely separate from the competition review. In Hong Kong, this most commonly arises in financial-services transactions where a Securities and Futures Commission licence or a banking authorisation held by a target entity must be novated or reapplied for as a condition of the acquisition.

Fourth, consider foreign-investment review in the acquirer's home market. Where the acquirer is a state-linked or strategically sensitive entity, the target-jurisdiction review is not the only constraint. Several G7 jurisdictions now operate investment-screening regimes that catch outbound acquisitions by certain categories of buyer, and those regimes look at the deal from the acquirer's side of the transaction. That exposure sits outside the Asia perimeter but feeds into the same closing timeline.

The output of this step is a jurisdiction matrix: a row for each competent authority, a column for obligation type, a column for estimated review period and a column for the consequence of filing late or closing early. That matrix is the foundation of the conditions-precedent schedule in the sale and purchase agreement.

Step 2: Sequencing the filings – what is the correct order and why does it matter?

Once the perimeter is mapped, the filings must be sequenced. The sequence is not arbitrary. It is determined by three factors: which regimes are pre-closing mandatory, which information requirements overlap, and which authorities have the longest expected review periods.

The longest mandatory review drives the critical path. For most Asia deals with Mainland nexus, that is the State Administration for Market Regulation review. A standard Phase 1 review on the Mainland runs to a defined statutory period; Phase 2 and Phase 3 reviews extend that window further. The deal timeline must be built around that timetable, not the other way around. Attempting to compress the Mainland review by rushing the filing – submitting an incomplete information package to hit a commercial deadline – is the single most common and most costly mistake we see on inbound Asia mandates.

The second sequencing consideration is information. Many competition filings require overlapping data: revenue by market and product line, market share estimates, details of the transaction structure and the post-merger entity. Preparing that data once, in a form that can be adapted for each filing, is materially more efficient than running parallel data-gathering exercises. Cross-border counsel co-ordinating across the filing jurisdictions will identify the common data core early and build the information architecture around it.

Third, some filings are sequentially dependent. A Mainland filing in its current form requires a finality of deal terms that is inconsistent with a preliminary non-binding offer. The filing timeline therefore typically begins after heads of terms are agreed, but the analysis should begin before that point so that the heads of terms themselves do not inadvertently trigger a mandatory filing by constituting a biaojue (determination of control) under the applicable rules.

For a deal with a Hong Kong holding layer, the Hong Kong step is usually administrative rather than substantive from a competition standpoint, but the licence-novation or licence-reapplication step in any regulated sector must sit on the same critical-path chart. It is not uncommon for a financial-services licence reapplication in Hong Kong to take longer than a straightforward competition filing in a smaller jurisdiction.

The sequence above describes the standard position. Your matter turns on the documents, the jurisdictions actually engaged, and the order of steps – which is where the route is won or lost. To discuss the clearance map for a specific transaction, write to us at info@lockhartyip.com.

Step 3: Structuring the conditions precedent and the long-stop date

The practical output of steps 1 and 2 is a set of conditions precedent in the sale and purchase agreement and a long-stop date that reflects the realistic outer boundary of the regulatory process. Getting these provisions right is as important as getting the filings right. A poorly drafted conditions-precedent schedule creates risk on both sides of the transaction.

On the buyer's side, the conditions precedent must be written with sufficient precision to distinguish between clearances that are genuinely required and approvals that would be commercially welcome but are not legally necessary for closing. Conflating the two inflates the number of conditions and gives the seller more grounds for dispute about whether a condition has been satisfied.

On the seller's side, the conditions must be defined in a way that does not give the buyer a mechanism to use a regulatory process as a device to delay closing or renegotiate price. A well-tested approach is to specify the exact filings required as conditions precedent, define the standard of clearance for each (approval, expiry of review period without objection, or specific confirmatory letter), and build the long-stop date around the longest expected mandatory review plus a negotiated buffer.

The long-stop date is one of the most negotiated provisions in an Asia M&A transaction. Sellers want a short long-stop; buyers facing a Mainland review or a multi-jurisdictional process need a realistic window. Our cross-border practice regularly advises on the calibration of that window – the starting point is the statutory review period of the longest mandatory filing, adjusted for the probability of a second-phase review and the complexity of the information package.

A further structural point: where the deal involves a waiziqi (foreign-invested enterprise) in the Mainland, the approval or record-filing step under the foreign-investment regime is separate from the competition filing and has its own timetable and competent authority. Both sit on the critical path. A deal timetable that tracks only the competition review and ignores the foreign-investment step will close late.

What is the most common mistake, and how does the correct route avoid it?

The most common mistake is treating merger control as a post-signing administrative formality rather than a pre-signing structuring question. The error typically manifests in three ways.

First, the transaction documents are signed on a timeline that does not reflect the mandatory review periods. The long-stop date is set by reference to a commercial closing target rather than the regulatory process, creating a structural mismatch from day one. The parties then spend the period between signing and the original long-stop date negotiating extensions and allocating the cost of the delay – a negotiation that should never have been necessary.

Second, the information package for the primary filing is prepared under time pressure after signing, when the deal team is already engaged in post-signing integration planning. A filing prepared under time pressure is more likely to generate a request for additional information from the reviewing authority, which restarts or extends the review clock. A filing prepared methodically before signing, with the benefit of a full data-gathering exercise, is more likely to be accepted as complete on first submission.

Third, the deal structure is fixed before the regulatory analysis is complete. Some structures are more efficient from a negotiation or tax standpoint but more complex from a regulatory standpoint. A share deal may trigger filings that an asset deal would not. A direct acquisition may require a licence-novation step that a newco structure avoids. These are not purely legal questions – they have direct commercial consequences for the timeline and cost of the transaction. They should be resolved before the structure is locked.

The correct route avoids all three of these errors by beginning the regulatory analysis at the same time as the due diligence exercise, treating the clearance map as an input to the transaction documents rather than an output of them, and building the filing timeline into the critical-path schedule from the first project-management meeting.

A manufacturing group with a Cayman holding entity and Mainland operating assets came to our desk in the autumn of 2025, having signed a share sale agreement with a long-stop date that did not accommodate the Mainland review period. We re-mapped the regulatory perimeter, identified two filings that had been overlooked in the original analysis, and advised on the re-negotiation of the conditions-precedent schedule and a revised long-stop. The transaction reached closing, though later than the parties had originally planned. The additional delay was the cost of the sequencing error at the pre-signing stage.

If an earlier filing, structure or enforcement attempt produced an adverse or stalled result, a second read can identify the strategic error and the routes still open. Write to us at info@lockhartyip.com for a structured reassessment.

How does the cross-border element affect the practical management of the process?

The cross-border element affects the process in three practical ways: co-ordination of advisers, co-ordination of information, and management of the reviewing authorities' expectations.

On adviser co-ordination: a multi-jurisdictional clearance process will typically involve local counsel in each filing jurisdiction and international counsel co-ordinating across the perimeter. The co-ordinating counsel's role is not to replicate the local analysis but to ensure that the filing strategy is consistent across jurisdictions, that the deal narrative presented to each authority is coherent, and that the critical-path management reflects the interaction between the different review clocks. In our cross-border M&A practice, that co-ordination function is the core of what we provide on a multi-filing transaction.

On information co-ordination: the data required for a Mainland competition filing, a Hong Kong licence-novation application and a foreign-investment review in a third market overlap significantly but not perfectly. Managing those overlapping data requirements through a single co-ordinated information-gathering exercise, rather than three separate processes, reduces the burden on the deal team and reduces the risk of inconsistency between filings – which is itself a regulatory risk. A discrepancy between the market-share figures in the Mainland filing and the same figures in a filing in another jurisdiction can generate questions that delay both reviews.

On authority management: different regulators have different expectations about the level of engagement during the review period. Some authorities expect a proactive dialogue from the filing party; others prefer a formal process with limited communication outside defined procedural windows. Calibrating the level and style of engagement with each authority is a judgment call that depends on experience with that authority's practice. International counsel with a cross-border practice that spans these jurisdictions will bring that calibration to the process; external local counsel who see the filing in isolation will not.

Decision checklist for in-house counsel

The following checklist is designed for a general counsel or legal director managing an Asia deal with a Hong Kong holding layer. It is not exhaustive, but it covers the questions that most commonly determine whether the regulatory process runs to plan.

Before signing:

• Has the full deal perimeter been identified – all jurisdictions in which the target group, the acquirer group or the combined group holds revenues, assets or market share above the applicable thresholds?
• Has the Mainland competition filing obligation been assessed against the current turnover thresholds (verified as at the date of the analysis)?
• Have sector-specific licence or consent requirements in Hong Kong and in every other jurisdiction been identified and mapped to the critical path?
• Has the foreign-investment review exposure in the acquirer's home jurisdiction been assessed?
• Has the deal structure been reviewed against the regulatory perimeter – specifically, whether a share deal, an asset deal, or an alternative acquisition vehicle changes the filing obligation or the licence-novation requirement?
• Has the Mainland waiziqi (foreign-invested enterprise) record-filing or approval step been mapped separately from the competition filing?
• Has a realistic long-stop date been agreed, built from the longest mandatory review period plus a negotiated buffer?

At signing:

• Are the conditions precedent precise – specifying the exact filings required, the standard of clearance, and the consequence of a conditional clearance?
• Is the long-stop date extendable by reference to an objective criterion (regulatory delay), not merely by mutual agreement?
• Is the filing obligation allocated to the correct party, with the other party's co-operation obligations defined?

Post-signing:

• Has the filing information package been prepared or is it already prepared – not commenced after signing?
• Is there a single point of co-ordination across all filing jurisdictions?
• Has the project management chart been updated to reflect the actual filing dates and the review-clock start dates for each jurisdiction?

Working through these questions before signing is the difference between a controlled process and a reactive one.

Where this sits in the broader transaction structure

Merger control and regulatory clearances are one element of a cross-border Asia transaction. They interact directly with the choice of acquisition vehicle for a Greater China deal – because the vehicle determines the filing perimeter. They interact with the governance provisions in the joint-venture or minority-investment documentation, because the clearance conditions shape the pre-closing obligations of each party. And they sit within the broader framework of M&A and transactions counsel for the transaction as a whole.

A clearance process that runs in isolation from the structural and governance workstreams creates avoidable risk. The most efficient approach treats the regulatory analysis, the vehicle design and the transaction documentation as a single integrated exercise, progressing in parallel from the earliest stage of the deal.

Related practices

• Holding Structures – design and review of holding vehicles above Hong Kong and offshore operating assets
• Tax Positions – territorial tax analysis, FSIE regime, and Pillar Two implications for cross-border transaction structures

Speak with Lockhart & Yip

For a scoped view of your matter, contact info@lockhartyip.com. Discuss your matter →

Related

• Ma Transactions
• Structuring Acquisition Vehicle Greater China Deal
• Minority Protections Mainland China Joint Venture Mainland China 3

This publication is general information and does not constitute legal advice. For advice on your situation, contact info@lockhartyip.com.